RYAM

Rayonier Advanced Materials Inc.

Fundamental data last updated:August 13, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Basic Materials

industry

Chemicals

Exchange

NYSE

County of HQ

US

Next Earnings Date

Pending Announcement

Business Summary

Rayonier Advanced Materials Inc. manufactures and sells cellulose specialty products in the United States, China, Canada, Japan, Europe, Latin America, other Asian countries, and internationally. The company operates through High Purity Cellulose, Paperboard, and High-Yield Pulp segments. Its products include cellulose specialties, which are natural polymers that are used as raw materials to manufacture a range of consumer-oriented products, such as liquid crystal displays, impact-resistant plastics, thickeners for food products, pharmaceuticals, cosmetics, cigarette filters, high-tenacity rayon yarn for tires and industrial hoses, food casings, paints, and lacquers. The company also offers commodity products, such as commodity viscose pulp used in woven applications, including rayon textiles for clothing and other fabrics, as well as in non-woven applications comprising baby wipes, cosmetic and personal wipes, industrial wipes, and mattress ticking; and absorbent materials consisting of fluff fibers that are used as an absorbent medium in disposable baby diapers, feminine hygiene products, incontinence pads, convalescent bed pads, industrial towels and wipes, and non-woven fabrics. In addition, it provides paperboards for packaging, printing documents, brochures, promotional materials, paperback books or catalog covers, file folders, tags, and tickets; and high-yield pulps to produce paperboard and packaging products, printing and writing papers, and various other paper products. The company was founded in 1926 and is headquartered in Jacksonville, Florida.

 


VALUATION

P/E

-1.32

Market Cap ($M USD)

$622.46M

Forward P/E

13.25

PEG

0.12

PRICE TO SALES

0.44

PRICE TO BOOK

2.70

EV / EBITDA

7.68

5-Year Average P/E

Free Cash Flow Yield

-13.52%

DCF Value

$3.95

Graham Number

N/A

Price to FCF

-7.39

EV to FCF

-15.66

Earnings Yield

-75.96%

FCF Yield

-13.52%

DIVIDEND

Yield

0.00%

Annual Payout

$0.00

Payout Ratio

0.00%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

-$7.01

Next Year EPS Growth Estimate

$0.70

Next Year Revenue Growth Estimate

$1.59B

Return on Equity (ROE)

-153.52%

FREE CASH FLOW

Operating Margin

0.48%

Debt-to-Equity

2.46

Piotroski F-Score

3

Altman Z-Score

1.08

Return on Invested Capital (ROIC)

0.54%

Current Ratio

1.37

Quick Ratio

0.79

Net Debt to EBITDA

4.05

Interest Coverage

0.07

Gross Profit margin

6.10%

FCF PER SHARE

$-1.25

REVENUE PER SHARE

$21.29

Gainseekers Quantitative Analysis

Summary

The market seems to have misjudged RYAM’s valuation. Despite a negative DCF Value, the stock’s Forward P/E of 12.72 suggests optimism for future earnings. However, the Altman Z-score of 0.93 indicates financial distress, raising red flags about its long-term viability. The negative Earnings Yield further underscores the lack of immediate profitability. Investors should be wary of the company’s precarious financial health, despite the market’s hopeful pricing.

AI Exposure / Tech Reliance

Operating in the Chemicals industry, RYAM is positioned to leverage AI for process optimization and cost reduction. However, the sector's traditional nature may slow tech adoption. The company's ability to integrate modern technologies will be crucial for maintaining competitiveness.

The Bull Case

For the optimistic investor, RYAM's Forward PEG ratio of 0.12 is a beacon of potential undervaluation. Despite a low Piotroski F-Score of 3, the anticipated sales growth suggests room for upside. While current margins are thin, the potential for improved capital efficiency could attract GARP investors looking for a turnaround story.

The Bear Case

RYAM's structural weaknesses are glaring. The Price/Book ratio of 2.68 and Price/Sales of 0.43 highlight a potentially overvalued stock relative to its book value and sales. With a Net Debt to EBITDA of 11.53, the company is heavily leveraged, and its negative FCF Yield signals poor cash flow management. Trading close to its 52-week high, the stock appears technically overextended, posing significant risk.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Hold

Average Analyst Price Target

$9.00

Institutional Ownership %

1-Year Beta

1.79

Insider Buying % (6 Mo)

Distance to 52-Week High

28.39%

Distance to 52-Week Low

63.71%

EARNINGS SURPRISE %

-96.77%

50-DAY SMA

$9.73

200-DAY SMA

$7.76

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.